| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | NEUTRAL | NEUTRAL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.54▲ | 5.54▲ | 5.45▲ | 5.65▼ | 5.72▼ |
| MA10 | 5.48▲ | 5.58▲ | 5.58▲ | 5.80▼ | 4.67▲ |
| MA20 | 5.60▲ | 5.68▼ | 5.68▼ | 5.85▼ | 3.91▲ |
| MA50 | 5.81▼ | 5.93▼ | 5.95▼ | 4.38▲ | 3.64▲ |
| MA100 | 5.92▼ | 5.80▼ | 5.48▲ | 3.81▲ | N/A |
| MA200 | 5.34▲ | 4.60▲ | 4.27▲ | 3.68▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.019▲ | -0.001▼ | -0.015▼ | -0.147▼ | 0.287▲ |
| RSI | 48.298▼ | 45.857▼ | 45.458▼ | 56.421▲ | 69.691▲ |
| STOCH | 68.117 | 50.062 | 35.864 | 24.632 | 36.984 |
| WILL %R | -27.778 | -43.478 | -44.286 | -72.881 | -61.616 |
| CCI | 36.842 | -26.470 | -33.424 | -88.132 | 62.127 |
|
Monday, February 22, 2021 08:11 AM
BiomX is a clinical-stage microbiome company using its novel BOLT phage therapy platform to develop customized phage therapies to treat chronic diseases ranging from IBC, colorectal cancer, Cystic ...
|
|
Thursday, February 18, 2021 03:10 AM
© 2021 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and ...
|
|
Tuesday, February 16, 2021 07:48 AM
Innoviva Inc (NASDAQ:INVA) has increased its stake in Armata Pharmaceuticals Inc (NASDAQ:ARMP). The more than 1.86 million shares added cost it around $6.07 million, at $3.25 per share.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/03/21 | 5.67 | 5.67 | 5.55 | 5.60 | 26,211 |
| 01/03/21 | 5.52 | 5.622 | 5.28 | 5.56 | 69,942 |
| 26/02/21 | 5.74 | 5.79 | 5.55 | 5.59 | 27,325 |
| 25/02/21 | 5.89 | 5.93 | 5.53 | 5.75 | 33,420 |
| 24/02/21 | 5.80 | 5.9354 | 5.75 | 5.75 | 13,102 |
| 23/02/21 | 5.79 | 5.9372 | 5.5001 | 5.70 | 10,649 |
| 22/02/21 | 5.53 | 6.00 | 5.53 | 5.88 | 18,646 |
| 19/02/21 | 6.08 | 6.18 | 5.72 | 5.74 | 29,904 |
| 18/02/21 | 6.24 | 6.24 | 6.0365 | 6.20 | 22,231 |
| 17/02/21 | 6.11 | 6.35 | 5.94 | 6.22 | 29,138 |
|
|
||||
|
|
||||
|
|